Global Acne Therapeutics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Acne Therapeutics Market Research Report 2024
Acne, also known as acne vulgaris, is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin.
According to MRAResearch’s new survey, global Acne Therapeutics market is projected to reach US$ 7857.1 million in 2033, increasing from US$ 6036.6 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acne Therapeutics market research.
US is Expected to Retain Largest Market Share. North America is expected to dominate the market owing to a rising awareness and the growing population of teenagers as well as the growing healthcare expenditure in the region. It is one of the most common disorders in the United States and affects a large section of teenagers and young adults including primarily the female patient’s population. Factors such as lifestyle changes, awareness programs regarding acne, and easy availability of acne treatments drive this market in this region. Apart from this, Asia-Pacific is expected to grow at a higher rate compared to other regions, due to a largely diversified patient pool including a major section of the population in the young adults age-group as well as the rising healthcare infrastructure.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Acne Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
GlaxoSmithKline
Pfizer
Johnson & Johnson
Roche
Teva Pharmaceutical
Bayer
Mylan
Allergan
Bausch Health
Nestle (Galderma)
Cipher Pharmaceuticals
Sun Pharmaceutical
Segment by Type
Topical Medication
Oral Medication
Inflammatory Acne
Non-inflammatory Acne
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acne Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Acne Therapeutics market is projected to reach US$ 7857.1 million in 2033, increasing from US$ 6036.6 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acne Therapeutics market research.
US is Expected to Retain Largest Market Share. North America is expected to dominate the market owing to a rising awareness and the growing population of teenagers as well as the growing healthcare expenditure in the region. It is one of the most common disorders in the United States and affects a large section of teenagers and young adults including primarily the female patient’s population. Factors such as lifestyle changes, awareness programs regarding acne, and easy availability of acne treatments drive this market in this region. Apart from this, Asia-Pacific is expected to grow at a higher rate compared to other regions, due to a largely diversified patient pool including a major section of the population in the young adults age-group as well as the rising healthcare infrastructure.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Acne Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GlaxoSmithKline
Pfizer
Johnson & Johnson
Roche
Teva Pharmaceutical
Bayer
Mylan
Allergan
Bausch Health
Nestle (Galderma)
Cipher Pharmaceuticals
Sun Pharmaceutical
Segment by Type
Topical Medication
Oral Medication
Segment by Application
Inflammatory Acne
Non-inflammatory Acne
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acne Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices